Triple-helical transition state analogues: A new class of selective matrix metalloproteinase inhibitors

被引:53
作者
Lauer-Fields, Janelle
Brew, Keith
Whitehead, John K.
Li, Shunzi
Hammer, Robert P.
Fields, Gregg B. [1 ]
机构
[1] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA
[2] Florida Atlantic Univ, Coll Biomed Sci, Boca Raton, FL 33431 USA
[3] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA
关键词
D O I
10.1021/ja0715849
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Alterations in activities of one family of proteases, the matrix metalloproteinases (MMPs), have been implicated in primary and metastatic tumor growth, angiogenesis, and pathological degradation of extracellular matrix (ECM) components, such as collagen and laminin. Since hydrolysis of the collagen triple-helix is one of the committed steps in ECM turnover, we envisioned modulation of collagenolytic activity as a strategy for creating selective MMP inhibitors. In the present study, a phosphinate transition state analogue has been incorporated within a triple-helical peptide template. The template sequence was based on the alpha 1(V)436-450 collagen region, which is hydrolyzed at the Gly(439)-Val(440) bond selectively by MMP-2 and MMP-9. The phosphinate acts as a tetrahedral transition state analogue, which mimics the water-bound peptide bond of a protein substrate during hydrolysis. The phosphinate replaced the amide bond between Gly-Val in the P-1-P-1' subsites of the triple-helical peptide. Inhibition studies revealed K-i values in the low nanomolar range for MMP-2 and MMP-9 and low to middle micromolar range for MMP-8 and MMP-13. MMP-1, MMP-3, and MT1-MMP/MMP-14 were not inhibited effectively. Melting of the triple-helix resulted in a decrease in inhibitor affinity for MMP-2. The phosphinate triple-helical transition state analogue has high affinity and selectivity for the gelatinases (MMP-2 and MMP-9) and represents a new class of protease inhibitors that maximizes potential selectivity via interactions with both prime and nonprime active site subsites as well as with secondary binding sites (exosites).
引用
收藏
页码:10408 / 10417
页数:10
相关论文
共 90 条
[1]
[Anonymous], 2001, Celltransmissions
[2]
[Anonymous], 2005, EVALUATION ENZYME IN
[3]
Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[4]
PHOSPHORUS-CONTAINING PEPTIDE ANALOGS AS PEPTIDASE INHIBITORS [J].
BARTLETT, PA ;
MARLOWE, CK ;
GIANNOUSIS, PP ;
HANSON, JE .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1987, 52 :83-90
[5]
Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine [J].
Beck, K ;
Chan, VC ;
Shenoy, N ;
Kirkpatrick, A ;
Ramshaw, JAM ;
Brodsky, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4273-4278
[6]
Beckett RP, 1996, EXPERT OPIN THER PAT, V6, P1305
[7]
Matrix metalloproteinase inhibitors 1998 [J].
Beckett, RP ;
Whittaker, M .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (03) :259-282
[8]
Design, modelling, synthesis and biological evaluation of peptidomimetic phosphinates as inhibitors of matrix metalloproteinases MMP-2 and MMP-8 [J].
Bianchini, G ;
Aschi, M ;
Cavicchio, G ;
Crucianelli, M ;
Preziuso, S ;
Gallina, C ;
Nastari, A ;
Gavuzzo, E ;
Mazza, F .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (15) :4740-4749
[9]
BOLIN DR, 1989, INT J PEPT PROT RES, V33, P353
[10]
Solid phase combinatorial library of phosphinic peptides for discovery of matrix metalloproteinase inhibitors [J].
Buchardt, J ;
Schiodt, CB ;
Krog-Jensen, C ;
Delaissé, JM ;
Foged, NT ;
Meldal, M .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2000, 2 (06) :624-638